Literature DB >> 22944460

Inflammation and neurodegeneration: the story 'retolled'.

Janelle Drouin-Ouellet1, Francesca Cicchetti.   

Abstract

Toll-like receptors (TLRs) play a crucial role in innate immunity by recognizing conserved motifs predominantly found in microorganisms. Increasing evidence supports a role for TLRs in sterile inflammation as observed in neurodegenerative disorders. This includes work suggesting a contribution for these receptors to the pathophysiology of Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders. In this review, the potential role of TLRs in the context of protein aggregation, neuronal degeneration, and genetic risk factors is addressed. In particular, we discuss the evidence derived from experimental models of both AD and PD which suggests that activation of TLRs can have beneficial and detrimental effects on pathological features such as protein aggregation and neuronal death. A deeper understanding of these dichotomous observations could be used for therapeutic benefit.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22944460     DOI: 10.1016/j.tips.2012.07.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  30 in total

Review 1.  Innate immune activation in Alzheimer's disease.

Authors:  Ming-Ming Wang; Dan Miao; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.

Authors:  Vera Paschon; Silvia Honda Takada; Juliane Midori Ikebara; Erica Sousa; Reza Raeisossadati; Henning Ulrich; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

3.  A novel protective role for the innate immunity Toll-Like Receptor 3 (TLR3) in the retina via Stat3.

Authors:  Amit K Patel; Abigail S Hackam
Journal:  Mol Cell Neurosci       Date:  2014-09-28       Impact factor: 4.314

4.  Zinc Potentiates Lipopolysaccharide-induced Nitric Oxide Production in Cultured Primary Rat Astrocytes.

Authors:  Mitsuaki Moriyama; Shunsuke Fujitsuka; Kenji Kawabe; Katsura Takano; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2017-11-09       Impact factor: 3.996

5.  Neuroprotective Effects of Dexmedetomidine Against Hypoxia-Induced Nervous System Injury are Related to Inhibition of NF-κB/COX-2 Pathways.

Authors:  Wanying Pan; Lin Lin; Nan Zhang; Fuli Yuan; Xiaoxiao Hua; Yueting Wang; Liqiu Mo
Journal:  Cell Mol Neurobiol       Date:  2015-12-18       Impact factor: 5.046

Review 6.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

7.  Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-κB and AP-1 Signaling Pathways In Vitro.

Authors:  Bin Hui; Liping Zhang; Qinhua Zhou; Ling Hui
Journal:  Neurotox Res       Date:  2017-11-08       Impact factor: 3.911

8.  Toll-like receptor 3 (TLR3) protects retinal pigmented epithelium (RPE) cells from oxidative stress through a STAT3-dependent mechanism.

Authors:  Amit K Patel; Abigail S Hackam
Journal:  Mol Immunol       Date:  2012-12-23       Impact factor: 4.407

Review 9.  An eye on the future of inflammasomes and drug development in AMD.

Authors:  Matthew Campbell; Sarah L Doyle
Journal:  J Mol Med (Berl)       Date:  2013-05-10       Impact factor: 4.599

Review 10.  The role of inflammation in sporadic and familial Parkinson's disease.

Authors:  Michela Deleidi; Thomas Gasser
Journal:  Cell Mol Life Sci       Date:  2013-05-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.